Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

11.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medicaid Retention After Transition to Medicare Among Adults With Expansion Coverage.

JAMA network open·2026
Same author

Resting-State Functional Magnetic Resonance Imaging of Interhemispheric Functional Connectivity in Experimental Traumatic Brain Injury.

Neurotrauma reports·2021
Same author

Intradural extramedullary spinal metastases from uterine carcinosarcoma: A case report.

Surgical neurology international·2020
Same author

Investigation of ventriculoperitoneal shunt disconnection for hydrocephalus treatment.

Journal of neurosurgery. Pediatrics·2020
Same author

Snuff box radial access: A technical note on distal radial access for neuroendovascular procedures.

Brain circulation·2019
Same author

Large Traumatic Skull Base Internal Carotid Artery Pseudoaneurysm managed With Endovascular Flow Diversion: 2-Dimensional Operative Video.

Operative neurosurgery (Hagerstown, Md.)·2018

Related Experiment Video

Updated: Apr 27, 2026

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria
06:55

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Published on: August 4, 2022

1.7K

Stroke neuroprotection: targeting mitochondria.

Lora Talley Watts1, Reginald Lloyd2, Richard Justin Garling3

  • 1Department of Cellular and Structural Biology, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA. wattsl@uthscsa.edu.

Brain Sciences
|June 26, 2014
PubMed
Summary

This review explores mitochondrial-targeting drugs for stroke neuroprotection. These agents aim to boost energy, reduce oxidative stress, and enhance antioxidant defenses to salvage brain tissue after ischemic stroke.

More Related Videos

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.1K
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.2K

Related Experiment Videos

Last Updated: Apr 27, 2026

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria
06:55

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Published on: August 4, 2022

1.7K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.1K
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.2K

Area of Science:

  • Neuroscience
  • Biomedical Science
  • Pharmacology

Background:

  • Stroke is a leading cause of death and disability, with limited treatment options.
  • Current treatments like recombinant tissue plasminogen activator (rt-PA) have a narrow therapeutic window.
  • Mitochondrial dysfunction is implicated in neurodegeneration following stroke.

Purpose of the Study:

  • To review mitochondrial-dependent therapeutic agents for neuroprotection in stroke.
  • To highlight mechanisms targeting mitochondria for stroke treatment.

Main Methods:

  • Literature review of studies on mitochondrial-targeted neuroprotective agents.
  • Analysis of mechanisms including purinergic receptor stimulation, superoxide dismutase, and methylene blue.

Main Results:

  • Mitochondrial dysfunction contributes to stroke-induced neurodegeneration.
  • Targeting mitochondria can enhance ATP production, reduce reactive oxygen species (ROS), and bolster antioxidant defenses.
  • Agents like methylene blue show promise for neuroprotection.

Conclusions:

  • Mitochondrial-dependent therapies offer a promising avenue for stroke neuroprotection.
  • These agents may expand treatment options beyond the current rt-PA window.
  • Further research into these agents could lead to improved stroke outcomes.